Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Improvement in Overall Survival in a Randomized Study That Compared Dacomitinib With Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer and <i>EGFR</i>-Activating Mutations
PaperCitations, authors & open-access status
Improvement in Overall Survival in a Randomized Study That Compared Dacomitinib With Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer and <i>EGFR</i>-Activating Mutations is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 439 citations, 2018 year and closed oa status.
439
Citations
2018
Year
closed
OA Status